Overview

NICE has terminated the medical technology guidance on Peezy Midstream for urine collection.

The Institute has been informed by the manufacturer that Peezy Midstream has been withdrawn from the UK market. NICE has therefore decided to suspend the guidance development in its current work programme

Next review - If NICE is notified about this topic again then it will follow the NICE topic prioritisation process.

NICE has terminated the medical technology guidance on Peezy Midstream for urine collection.

Status:
Suspended
Technology type:
Device
Decision:
Selected
Prioritisation programme:
HealthTech
Rationale:
Prioritisation board noted that the evidence suggested the technology was not effective for key outcomes. It was agreed that there was no value to the system in producing guidance that did not support the technology.

 

ID number:
446

Project Team

Project lead
Lizzy Latimer

Email enquiries

If you have any queries please email MedTech@nice.org.uk

Timeline

Key events during the development of the guidance:

Date Update
25 June 2026 Overview - Note added to the project documents
28 January 2022 Awaiting development. Status change linked to topic prioritisation decision being set to Selected
28 January 2022 Suspended
13 November 2019 Scope published
07 October 2019 Stakeholder registration opens

For further information on our processes and methods, please see our CHTE processes and methods manual